7.4 Inhaled Medication Delivery Technique and Patient Education
Key Takeaways
- Inhaled medication delivery appears as task 3 under all three Domain II verbs, so the exam tests device selection, correct administration, and how to judge whether the dose actually reached the lung.
- Pressurized metered dose inhalers require a slow deep inspiration of about 30 L/min with a 10-second breath hold, while dry powder inhalers require a fast forceful inspiration and must never be exhaled into.
- A valved holding chamber removes the need for hand-breath coordination and reduces oropharyngeal deposition, which is why bronchodilator-response protocols specify four separate actuations through a spacer.
- Patient education is its own scored task (Domain II item 11) covering medication delivery technique, asthma action plans, and air-travel oxygen planning.
- Commercial aircraft cabins are pressurized to a maximum equivalent altitude of 8,000 feet, which is why a hypoxic altitude simulation test uses an inspired oxygen fraction of about 15%.
7.4 Inhaled Medication Delivery Technique and Patient Education
Two Domain II tasks are almost always underestimated by candidates: item 3, inhaled medication delivery and item 11, patient education. Both are examined under all three task verbs — select, perform, and evaluate validity — which means roughly a dozen scored items can touch them. They matter clinically for the same reason: a bronchodilator-response study is only as valid as the drug that actually reached the airway, and a patient who leaves the laboratory unable to use their inhaler correctly has received a diagnosis without a treatment.
Device Classes and the Inspiratory Maneuver Each Requires
The single most testable concept is that different devices require opposite breathing patterns. Coaching a patient into the wrong maneuver wastes the dose.
| Device | Required Inspiration | Breath Hold | Key Failure Mode |
|---|---|---|---|
| Pressurized MDI (pMDI) | Slow and deep, about 30 L/min over 4–5 s | 10 seconds | Actuation–inhalation mismatch; cold-Freon reflex |
| pMDI + valved holding chamber | Slow and deep, or tidal breathing in small children | 10 s (or 5–6 tidal breaths) | Electrostatic charge on a new plastic chamber |
| Soft mist inhaler | Slow and deep | 10 seconds | Failure to prime/twist the base fully |
| Dry powder inhaler (DPI) | Fast and forceful from the start | 10 seconds | Inadequate inspiratory flow; exhaling into the device |
| Small-volume jet nebulizer | Normal tidal breathing with occasional deep breaths | Not required | Fill volume, driving flow, and tapping the reservoir |
- pMDI physics. A pressurized canister fires a plume that is initially fast-moving; a slow inhalation lets the propellant evaporate and the particles decelerate so they reach the lower airway rather than impacting on the posterior pharynx. Firing during a fast inhalation deposits more drug in the throat.
- DPI physics. The drug is a micronized powder blended with a carrier such as lactose. Only turbulent energy generated by the patient's own fast inspiration disaggregates the powder into respirable particles. A patient generating inadequate inspiratory flow — severe obstruction, muscle weakness, young children — receives little drug from a DPI regardless of technique. Exhaling into a DPI adds humidity that clumps the powder and can blow the metered dose away entirely.
Correct pMDI Technique, Step by Step
- Remove the cap and inspect the actuator orifice for drug residue.
- Shake for 5 seconds. Suspension formulations separate.
- Prime if new or unused for the interval stated in the package insert.
- Exhale to functional residual capacity — not a forced exhalation to residual volume.
- Place the mouthpiece between the teeth with lips sealed (or use a spacer).
- Begin a slow inspiration, then actuate once within the first quarter of the breath.
- Continue inhaling slowly to total lung capacity.
- Hold the breath 10 seconds, then exhale slowly.
- Wait 30–60 seconds between actuations.
- Rinse and spit after inhaled corticosteroids to prevent oropharyngeal candidiasis.
The Valved Holding Chamber
A spacer with a one-way valve accomplishes three things: it removes the need for hand-breath coordination, it allows propellant to evaporate so the particle size distribution shifts into the respirable range, and it traps large particles that would otherwise deposit in the oropharynx. That is precisely why the standard bronchodilator-response protocol calls for four separate actuations, each individually inhaled through a spacer with a 30-second interval, rather than four rapid puffs. New plastic chambers carry an electrostatic charge that attracts drug to the wall; wash with dilute detergent and air dry without rinsing or wiping to leave an antistatic film.
Evaluating Whether the Dose Was Actually Delivered
Domain II.C asks the technologist to evaluate the validity of inhaled medication delivery. Concretely:
- Watch the maneuver. Cheeks ballooning, a plume escaping from the lips, a whistling spacer flow-signal (many chambers whistle when inspiration is too fast), or a patient who exhales immediately after actuation all indicate a failed dose.
- Check the count. Dose counters exist for a reason; a canister that floats is not a valid emptiness test.
- Reconcile with the physiology. A post-bronchodilator study showing a fall in FEV$_1$ raises three possibilities, in order: submaximal post-dose effort, genuine paradoxical bronchoconstriction (rare, usually to a propellant or preservative), or failed delivery.
- Repeat with a different route. If technique cannot be corrected, deliver the bronchodilator by jet nebulizer and document the change; the report must state the drug, dose, device, and time interval before the post-dose maneuver.
Patient Education: The Three Topics the Outline Names
The DCO gives three examples for item 11 — medication delivery, travel, and asthma — and each is a distinct teaching task.
1. Medication Delivery Education
Teach-back is the standard: demonstrate, then have the patient demonstrate to you. Roughly two-thirds of patients make at least one critical error with a pMDI, and the most common ones are failure to shake, failure to exhale first, actuating after inhalation has begun in earnest, and no breath hold. Document which device the patient uses at home and any error corrected.
2. Travel Education and Air-Travel Oxygen
Commercial aircraft cabins are pressurized to a maximum equivalent altitude of 8,000 feet, where barometric pressure falls to roughly 565 mmHg and inspired PO$_2$ falls accordingly. A patient with borderline resting oxygenation at sea level can become significantly hypoxemic in flight.
- Screening rule of thumb: a resting sea-level SpO$_2$ below 92% (or PaO$_2$ below 70 mmHg) generally warrants formal assessment before flying.
- Hypoxic altitude simulation test (HAST): the patient breathes a hypoxic mixture of about 15% oxygen (nitrogen balance), simulating 8,000 feet, while SpO$_2$ and often arterial blood gases are monitored. In-flight supplemental oxygen is typically recommended if PaO$_2$ falls below 50–55 mmHg.
- Practical counseling: portable oxygen concentrators must be airline-approved and carried with sufficient battery life, airlines require advance notice, and patients should carry medications in the cabin rather than in checked baggage.
3. Asthma Education and the Action Plan
A written asthma action plan is built around the patient's personal best peak expiratory flow, established over two to three weeks of good control:
- Green zone (80–100% of personal best): good control; continue maintenance therapy.
- Yellow zone (50–80%): worsening; use quick-relief medication as prescribed and follow the plan's step-up instructions.
- Red zone (below 50%): medical alert; take rescue medication and seek immediate care.
Reinforce trigger avoidance, the distinction between controller and reliever inhalers (a patient who reaches for a corticosteroid during an attack has a dangerous misunderstanding), correct peak-flow-meter technique with the marker reset to zero and the best of three efforts recorded, and the fact that a peak flow meter measures large-airway flow and can look reassuring while small-airway obstruction worsens.
A patient with severe COPD (FEV1 28% predicted) cannot generate a forceful inspiration. Which delivery device is least likely to deliver an effective dose, and why?
A patient with interstitial lung disease has a resting sea-level SpO2 of 90% and plans a long flight. What assessment is indicated and what inspired oxygen fraction simulates a commercial cabin?
Post-bronchodilator spirometry shows an FEV1 that is 90 mL LOWER than baseline. The technologist observed a plume of aerosol escaping from the patient's lips at actuation. What is the most appropriate interpretation and action?